These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8677322)

  • 21. The cost-effectiveness of mammography screening: evidence from a microsimulation model for New Zealand.
    Szeto KL; Devlin NJ
    Health Policy; 1996 Nov; 38(2):101-15. PubMed ID: 10160378
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A quest for quality and economic effectiveness throughout the continuum of breast care.
    La Fargue MM; Coleman C
    Breast; 2010 Aug; 19(4):251-2. PubMed ID: 20392641
    [No Abstract]   [Full Text] [Related]  

  • 23. Swiss Medical Board Mammography screening predictions for Switzerland: importance of time-periods.
    de Koning HJ; Heijnsdijk EA
    J Med Screen; 2015 Dec; 22(4):201-6. PubMed ID: 26018779
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of effectiveness of quality-assured mammography screening in Germany: sample size considerations and design options.
    Becker N; Hakama M; Nyström L
    Eur J Cancer Prev; 2007 Jun; 16(3):225-31. PubMed ID: 17415093
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Mammography screening. Senselessly squandered money?].
    Rautenstrauch J
    MMW Fortschr Med; 2000 Mar; 142(12):4-8. PubMed ID: 10804710
    [No Abstract]   [Full Text] [Related]  

  • 26. Mammography screening: an incremental cost effectiveness analysis of two view versus one view procedures in London.
    Bryan S; Brown J; Warren R
    J Epidemiol Community Health; 1995 Feb; 49(1):70-8. PubMed ID: 7707010
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A model-based comparison of breast cancer screening strategies: mammograms and clinical breast examinations.
    Shen Y; Parmigiani G
    Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):529-32. PubMed ID: 15734983
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mammography screening: prospects and opportunity costs.
    Navarro AM; Kaplan RM
    Womens Health; 1996; 2(4):209-33. PubMed ID: 9421557
    [TBL] [Abstract][Full Text] [Related]  

  • 29. UKCCCR multicentre randomised controlled trial of one and two view mammography in breast cancer screening.
    Wald NJ; Murphy P; Major P; Parkes C; Townsend J; Frost C
    BMJ; 1995 Nov; 311(7014):1189-93. PubMed ID: 7488893
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Offering mammography is beneficial in the long run].
    Cederblom S
    Lakartidningen; 1995 Dec; 92(51-52):4865-8. PubMed ID: 8544497
    [No Abstract]   [Full Text] [Related]  

  • 31. Breast cancer screening for women aged 40 to 49 years--what does the evidence mean for New Zealand?
    Baker S; Wall M; Bloomfield A
    N Z Med J; 2005 Aug; 118(1221):U1628. PubMed ID: 16138166
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Breast cancer screening among women younger than age 50: a current assessment of the issues.
    Smith RA
    CA Cancer J Clin; 2000; 50(5):312-36. PubMed ID: 11075240
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Concept and implementation of model projects for mammography screening in Germany].
    Junkermann H; Becker N; Peitgen HO
    Radiologe; 2001 Apr; 41(4):328-36. PubMed ID: 11388053
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Economic approach to breast cancer screening in Belgium].
    Grivegnée AR; Autier P
    Rev Med Brux; 2001 Sep; 22(4):A277-81. PubMed ID: 11680188
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cost-effectiveness of the Norwegian breast cancer screening program.
    van Luijt PA; Heijnsdijk EA; de Koning HJ
    Int J Cancer; 2017 Feb; 140(4):833-840. PubMed ID: 27861849
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Breast cancer detection: improving the efficacy of screening mammography.
    Brecheisen NL; Snyder TE
    Kans Med; 1994 Apr; 95(4):90-3. PubMed ID: 8041052
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Benefits and costs of screening and treatment for early breast cancer. Development of a basic benefit package.
    Kattlove H; Liberati A; Keeler E; Brook RH
    JAMA; 1995 Jan; 273(2):142-8. PubMed ID: 7799495
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Costs of breast cancer and the cost-effectiveness of breast cancer screening.
    Elixhauser A
    Int J Technol Assess Health Care; 1991; 7(4):604-15. PubMed ID: 1778705
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dutch digital breast cancer screening: implications for breast cancer care.
    Timmers JM; den Heeten GJ; Adang EM; Otten JD; Verbeek AL; Broeders MJ
    Eur J Public Health; 2012 Dec; 22(6):925-9. PubMed ID: 22158996
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Summaries for patients. The cost-effectiveness of mammography in women older than 65 years of age.
    Ann Intern Med; 2003 Nov; 139(10):I34. PubMed ID: 14623641
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.